```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 182 Received in Senate (RDS)]

  1st Session
H. CON. RES. 182

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 17, 2007

                                Received

_______________________________________________________________________

                         CONCURRENT RESOLUTION

 
 Recognizing the need to pursue research into the causes, a treatment, 
and an eventual cure for idiopathic pulmonary fibrosis, supporting the 
 goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness 
                     Week, and for other purposes.

Whereas idiopathic pulmonary fibrosis is a serious lung disorder causing 
        progressive, incurable lung scarring;
Whereas idiopathic pulmonary fibrosis is one of about 200 disorders called 
        interstitial lung diseases;
Whereas idiopathic pulmonary fibrosis is the most common form of interstitial 
        lung disease;
Whereas idiopathic pulmonary fibrosis is a debilitating and generally fatal 
        disease marked by progressive scarring of the lungs, causing an 
        irreversible loss of the lung tissue's ability to transport oxygen;
Whereas idiopathic pulmonary fibrosis progresses quickly, often causing 
        disability or death within a few short years;
Whereas there is no proven cause of idiopathic pulmonary fibrosis;
Whereas more than 128,000 United States citizens have idiopathic pulmonary 
        fibrosis, and more than 48,000 new cases are diagnosed each year 
        representing a 156-percent increase in mortality since 2001;
Whereas idiopathic pulmonary fibrosis is often misdiagnosed or under diagnosed;
Whereas the median survival rate for idiopathic pulmonary fibrosis patients is 2 
        to 3 years; about two-thirds of idiopathic pulmonary fibrosis patients 
        die within 5 years; and approximately 40,000 patients die each year; and
Whereas a need has been identified to increase awareness and detection of this 
        misdiagnosed and under diagnosed disorder as well as all incarnations of 
        pulmonary fibrosis: Now, therefore, be it
    Resolved by the House of Representatives (the Senate concurring), 
That the Congress--
            (1) recognizes the need to pursue research into the causes, 
        a treatment, and an eventual cure for idiopathic pulmonary 
        fibrosis;
            (2) supports the work of advocates and organizations in 
        educating, supporting, and providing hope for individuals who 
        suffer from idiopathic pulmonary fibrosis, including efforts to 
        organize a National Idiopathic Pulmonary Fibrosis Awareness 
        Week;
            (3) supports the designation of an appropriate week as 
        National Idiopathic Pulmonary Fibrosis Awareness Week;
            (4) welcomes the issuance of a proclamation designating a 
        National Idiopathic Pulmonary Fibrosis Awareness Week;
            (5) congratulates advocates and organizations for their 
        efforts to educate the public about idiopathic pulmonary 
        fibrosis, while funding research to help find a cure for this 
        disorder; and
            (6) supports the goals and ideals of National Idiopathic 
        Pulmonary Fibrosis Awareness Week.

            Passed the House of Representatives October 16, 2007.

            Attest:

                                            LORRAINE C. MILLER,

                                                                 Clerk.
```